STAT1 and cervical carcinoma: Indeed, despite the wide distribution of our proteins of interest over different tissues/cell types and the associated possibility of side effects, targeting the ANXA2-NDRG1-STAT1-mediated pathways may be a promising therapeutic approach in cervical cancer, deserving attention in future studies.